Logo image of KAVL

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

NASDAQ:KAVL - Nasdaq - US4831044023 - Common Stock

1.22  +0.09 (+7.96%)

After market: 1.1322 -0.09 (-7.2%)

Fundamental Rating

1

Taking everything into account, KAVL scores 1 out of 10 in our fundamental rating. KAVL was compared to 15 industry peers in the Distributors industry. Both the profitability and financial health of KAVL have multiple concerns. KAVL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

KAVL had negative earnings in the past year.
In the past year KAVL has reported a negative cash flow from operations.
In the past 5 years KAVL reported 4 times negative net income.
KAVL had negative operating cash flow in 4 of the past 5 years.
KAVL Yearly Net Income VS EBIT VS OCF VS FCFKAVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

With a Return On Assets value of -45.44%, KAVL is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
KAVL's Return On Equity of -58.89% is on the low side compared to the rest of the industry. KAVL is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
ROA -45.44%
ROE -58.89%
ROIC N/A
ROA(3y)-67.82%
ROA(5y)N/A
ROE(3y)-94.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KAVL Yearly ROA, ROE, ROICKAVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 150

1.3 Margins

KAVL has a Gross Margin (28.94%) which is in line with its industry peers.
KAVL's Gross Margin has improved in the last couple of years.
KAVL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.95%
GM growth 5YN/A
KAVL Yearly Profit, Operating, Gross MarginsKAVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

3

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KAVL has more shares outstanding
The number of shares outstanding for KAVL has been increased compared to 5 years ago.
KAVL has a worse debt/assets ratio than last year.
KAVL Yearly Shares OutstandingKAVL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M
KAVL Yearly Total Debt VS Total AssetsKAVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

KAVL has an Altman-Z score of -2.09. This is a bad value and indicates that KAVL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.09, KAVL is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
KAVL has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, KAVL is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.09
ROIC/WACCN/A
WACC12.9%
KAVL Yearly LT Debt VS Equity VS FCFKAVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.76 indicates that KAVL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.76, KAVL is in line with its industry, outperforming 50.00% of the companies in the same industry.
KAVL has a Quick Ratio of 1.70. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.70, KAVL is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.7
KAVL Yearly Current Assets VS Current LiabilitesKAVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.68% over the past year.
Looking at the last year, KAVL shows a very negative growth in Revenue. The Revenue has decreased by -16.74% in the last year.
Measured over the past years, KAVL shows a very negative growth in Revenue. The Revenue has been decreasing by -41.18% on average per year.
EPS 1Y (TTM)39.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-16.74%
Revenue growth 3Y-41.18%
Revenue growth 5YN/A
Sales Q2Q%-80.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y200%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year101.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KAVL Yearly Revenue VS EstimatesKAVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
KAVL Yearly EPS VS EstimatesKAVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KAVL. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 29.90, which means the current valuation is very expensive for KAVL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KAVL is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 24.44. KAVL is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 29.9
KAVL Price Earnings VS Forward Price EarningsKAVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KAVL Per share dataKAVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

KAVL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KAVL!.
Industry RankSector Rank
Dividend Yield N/A

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (1/21/2025, 8:10:30 PM)

After market: 1.1322 -0.09 (-7.2%)

1.22

+0.09 (+7.96%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)09-17 2024-09-17
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner Change0%
Ins Owners0.18%
Ins Owner Change0%
Market Cap8.27M
Analysts82.86
Price TargetN/A
Short Float %3.65%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-93.91%
Min Revenue beat(2)-97.22%
Max Revenue beat(2)-90.59%
Revenue beat(4)0
Avg Revenue beat(4)-88.61%
Min Revenue beat(4)-97.22%
Max Revenue beat(4)-80.79%
Revenue beat(8)0
Avg Revenue beat(8)-70.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.9
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)-2.59
EYN/A
EPS(NY)0.04
Fwd EY3.34%
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS1.49
BVpS2
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.44%
ROE -58.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.94%
FCFM N/A
ROA(3y)-67.82%
ROA(5y)N/A
ROE(3y)-94.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.95%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.7
Altman-Z -2.09
F-Score6
WACC12.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y200%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.74%
Revenue growth 3Y-41.18%
Revenue growth 5YN/A
Sales Q2Q%-80.08%
Revenue Next Year101.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.97%
OCF growth 3YN/A
OCF growth 5YN/A